Jonathan Michael Marron, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Treatment Refusal | 4 | 2021 | 433 | 1.690 |
Why?
|
Medical Oncology | 18 | 2024 | 2341 | 1.610 |
Why?
|
Ethics Consultation | 4 | 2024 | 59 | 1.240 |
Why?
|
Patient Participation | 3 | 2022 | 1446 | 1.190 |
Why?
|
Neoplasms | 22 | 2024 | 22369 | 1.160 |
Why?
|
Decision Making | 10 | 2024 | 3953 | 1.090 |
Why?
|
Dissent and Disputes | 3 | 2023 | 150 | 1.070 |
Why?
|
Hodgkin Disease | 2 | 2021 | 1383 | 0.860 |
Why?
|
Informed Consent By Minors | 1 | 2021 | 9 | 0.750 |
Why?
|
Medical Futility | 2 | 2024 | 136 | 0.720 |
Why?
|
Parental Consent | 1 | 2021 | 63 | 0.720 |
Why?
|
Healthcare Disparities | 3 | 2021 | 3415 | 0.700 |
Why?
|
Metaphor | 1 | 2020 | 41 | 0.690 |
Why?
|
Complementary Therapies | 2 | 2021 | 487 | 0.680 |
Why?
|
Parents | 12 | 2024 | 3595 | 0.660 |
Why?
|
Brain Death | 1 | 2023 | 360 | 0.650 |
Why?
|
Personal Autonomy | 1 | 2021 | 316 | 0.630 |
Why?
|
Informed Consent | 4 | 2022 | 1010 | 0.620 |
Why?
|
Social Justice | 2 | 2024 | 487 | 0.600 |
Why?
|
Ethics | 1 | 2017 | 93 | 0.560 |
Why?
|
Physician-Patient Relations | 4 | 2019 | 3269 | 0.550 |
Why?
|
Genetic Testing | 4 | 2024 | 3591 | 0.550 |
Why?
|
Pediatrics | 6 | 2024 | 3629 | 0.520 |
Why?
|
Morals | 2 | 2020 | 288 | 0.520 |
Why?
|
Communication | 6 | 2024 | 3905 | 0.520 |
Why?
|
Bioethics | 1 | 2017 | 118 | 0.510 |
Why?
|
Liver Failure | 1 | 2017 | 252 | 0.490 |
Why?
|
Resuscitation Orders | 1 | 2017 | 271 | 0.490 |
Why?
|
Withholding Treatment | 2 | 2024 | 620 | 0.460 |
Why?
|
Immunotherapy, Adoptive | 1 | 2024 | 1512 | 0.450 |
Why?
|
Truth Disclosure | 1 | 2017 | 434 | 0.440 |
Why?
|
Pandemics | 4 | 2021 | 8750 | 0.430 |
Why?
|
Neuroblastoma | 1 | 2021 | 1266 | 0.410 |
Why?
|
Terminal Care | 3 | 2023 | 1770 | 0.410 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.400 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3238 | 0.400 |
Why?
|
Hospitals, Pediatric | 4 | 2024 | 1874 | 0.400 |
Why?
|
Social Class | 1 | 2021 | 2007 | 0.390 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2023 | 1483 | 0.390 |
Why?
|
Death | 1 | 2016 | 683 | 0.380 |
Why?
|
Referral and Consultation | 1 | 2024 | 3619 | 0.370 |
Why?
|
Child | 21 | 2024 | 80905 | 0.340 |
Why?
|
Health Care Rationing | 3 | 2024 | 435 | 0.340 |
Why?
|
Health Status Disparities | 1 | 2021 | 1885 | 0.330 |
Why?
|
Osteosarcoma | 1 | 2015 | 911 | 0.320 |
Why?
|
Secondary Prevention | 1 | 2015 | 1474 | 0.310 |
Why?
|
Humans | 58 | 2024 | 767998 | 0.300 |
Why?
|
Hematology | 2 | 2022 | 243 | 0.300 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 2020 | 3626 | 0.290 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7851 | 0.280 |
Why?
|
Attitude of Health Personnel | 3 | 2024 | 3930 | 0.270 |
Why?
|
Bone Neoplasms | 2 | 2016 | 2564 | 0.260 |
Why?
|
National Cancer Institute (U.S.) | 2 | 2024 | 300 | 0.250 |
Why?
|
Hematologic Neoplasms | 1 | 2017 | 1907 | 0.250 |
Why?
|
Therapeutic Human Experimentation | 1 | 2005 | 43 | 0.240 |
Why?
|
Interprofessional Relations | 1 | 2010 | 997 | 0.230 |
Why?
|
Therapies, Investigational | 1 | 2005 | 110 | 0.230 |
Why?
|
Drug Industry | 1 | 2010 | 791 | 0.230 |
Why?
|
Cholecystectomy, Laparoscopic | 1 | 2005 | 236 | 0.210 |
Why?
|
Stress, Psychological | 1 | 2018 | 4529 | 0.200 |
Why?
|
Adolescent | 12 | 2024 | 89154 | 0.200 |
Why?
|
Ethics, Clinical | 2 | 2023 | 101 | 0.200 |
Why?
|
Paternalism | 1 | 2022 | 49 | 0.200 |
Why?
|
Connecticut | 1 | 2021 | 365 | 0.180 |
Why?
|
Ethical Theory | 1 | 2020 | 34 | 0.180 |
Why?
|
Colectomy | 1 | 2005 | 696 | 0.170 |
Why?
|
Bereavement | 1 | 2023 | 310 | 0.160 |
Why?
|
Prognosis | 3 | 2024 | 29984 | 0.160 |
Why?
|
Herbal Medicine | 1 | 2019 | 37 | 0.160 |
Why?
|
Mass Media | 1 | 2021 | 303 | 0.150 |
Why?
|
Parental Notification | 1 | 2017 | 12 | 0.150 |
Why?
|
Infant | 6 | 2024 | 36533 | 0.150 |
Why?
|
State Government | 1 | 2021 | 388 | 0.150 |
Why?
|
Cultural Diversity | 1 | 2021 | 373 | 0.140 |
Why?
|
Ethics, Research | 1 | 2018 | 178 | 0.140 |
Why?
|
Professional-Family Relations | 1 | 2021 | 501 | 0.140 |
Why?
|
Patients | 1 | 2023 | 908 | 0.130 |
Why?
|
Standard of Care | 1 | 2021 | 569 | 0.130 |
Why?
|
Radiation Oncology | 1 | 2022 | 572 | 0.130 |
Why?
|
Professional-Patient Relations | 1 | 2021 | 724 | 0.130 |
Why?
|
Uncertainty | 1 | 2020 | 769 | 0.130 |
Why?
|
Remission Induction | 1 | 2021 | 2409 | 0.120 |
Why?
|
Esthesioneuroblastoma, Olfactory | 1 | 2015 | 58 | 0.120 |
Why?
|
Choice Behavior | 1 | 2021 | 848 | 0.120 |
Why?
|
History, 21st Century | 1 | 2021 | 1572 | 0.120 |
Why?
|
Health Communication | 1 | 2017 | 216 | 0.120 |
Why?
|
Specialties, Surgical | 1 | 2019 | 391 | 0.120 |
Why?
|
Fear | 1 | 2023 | 1495 | 0.110 |
Why?
|
Child, Preschool | 5 | 2024 | 42665 | 0.110 |
Why?
|
Ethics, Medical | 1 | 2019 | 785 | 0.110 |
Why?
|
Nasal Cavity | 1 | 2015 | 310 | 0.110 |
Why?
|
Nose Neoplasms | 1 | 2015 | 250 | 0.110 |
Why?
|
Qualitative Research | 1 | 2024 | 3141 | 0.110 |
Why?
|
Gender Identity | 1 | 2019 | 770 | 0.100 |
Why?
|
Trust | 1 | 2017 | 532 | 0.100 |
Why?
|
Adult | 8 | 2024 | 223577 | 0.100 |
Why?
|
Fatal Outcome | 1 | 2017 | 1836 | 0.100 |
Why?
|
Internet | 1 | 2024 | 3111 | 0.100 |
Why?
|
Male | 13 | 2024 | 364638 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2421 | 0.100 |
Why?
|
Databases, Genetic | 1 | 2018 | 1758 | 0.090 |
Why?
|
Cerebellar Neoplasms | 1 | 2016 | 591 | 0.090 |
Why?
|
Critical Care | 2 | 2024 | 2715 | 0.090 |
Why?
|
Burnout, Professional | 1 | 2020 | 711 | 0.090 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2666 | 0.090 |
Why?
|
Minority Groups | 1 | 2018 | 1217 | 0.090 |
Why?
|
Medulloblastoma | 1 | 2016 | 683 | 0.090 |
Why?
|
Pilot Projects | 1 | 2024 | 8740 | 0.090 |
Why?
|
Clinical Trials as Topic | 3 | 2024 | 8052 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6786 | 0.090 |
Why?
|
Cancer Care Facilities | 2 | 2024 | 427 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2021 | 1946 | 0.080 |
Why?
|
Poverty | 1 | 2021 | 2720 | 0.080 |
Why?
|
United States | 5 | 2024 | 73033 | 0.080 |
Why?
|
Marketing | 1 | 2010 | 224 | 0.080 |
Why?
|
Psychometrics | 1 | 2017 | 3062 | 0.070 |
Why?
|
Genomics | 3 | 2024 | 5925 | 0.070 |
Why?
|
Public Health | 1 | 2021 | 2682 | 0.070 |
Why?
|
Cohort Studies | 2 | 2021 | 41753 | 0.070 |
Why?
|
Practice Guidelines as Topic | 2 | 2021 | 7439 | 0.070 |
Why?
|
Conflict of Interest | 1 | 2010 | 556 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3464 | 0.060 |
Why?
|
Young Adult | 4 | 2021 | 60050 | 0.060 |
Why?
|
Needs Assessment | 1 | 2010 | 1141 | 0.060 |
Why?
|
Female | 8 | 2024 | 397102 | 0.060 |
Why?
|
Internship and Residency | 1 | 2024 | 5953 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3840 | 0.060 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 26377 | 0.050 |
Why?
|
Ethicists | 1 | 2022 | 39 | 0.050 |
Why?
|
Anxiety | 1 | 2017 | 4672 | 0.050 |
Why?
|
Paranasal Sinuses | 1 | 2005 | 267 | 0.050 |
Why?
|
Life Support Care | 1 | 2024 | 226 | 0.050 |
Why?
|
Middle Aged | 4 | 2024 | 223422 | 0.050 |
Why?
|
Organizational Policy | 1 | 2024 | 435 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5717 | 0.050 |
Why?
|
Ethics Committees | 1 | 2020 | 51 | 0.040 |
Why?
|
Unnecessary Procedures | 1 | 2024 | 412 | 0.040 |
Why?
|
Patient Rights | 1 | 2021 | 126 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2021 | 202 | 0.040 |
Why?
|
Australia | 1 | 2023 | 1265 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2021 | 13658 | 0.040 |
Why?
|
Depression | 1 | 2017 | 8231 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9412 | 0.040 |
Why?
|
Health Priorities | 1 | 2021 | 380 | 0.040 |
Why?
|
Ambulatory Care Facilities | 1 | 2024 | 939 | 0.040 |
Why?
|
Infant, Newborn | 1 | 2017 | 26418 | 0.040 |
Why?
|
Penetrance | 1 | 2019 | 388 | 0.040 |
Why?
|
Documentation | 1 | 2023 | 917 | 0.030 |
Why?
|
Educational Status | 1 | 2022 | 2514 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2024 | 2783 | 0.030 |
Why?
|
Language | 1 | 2023 | 1558 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2005 | 3573 | 0.030 |
Why?
|
Self Efficacy | 1 | 2016 | 643 | 0.020 |
Why?
|
Patient Satisfaction | 1 | 2023 | 3488 | 0.020 |
Why?
|
Aged | 3 | 2019 | 171453 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3387 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3965 | 0.020 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2337 | 0.020 |
Why?
|
Palliative Care | 1 | 2021 | 3642 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2016 | 2824 | 0.010 |
Why?
|
Research Design | 1 | 2020 | 6212 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2015 | 65360 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2015 | 8536 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5366 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18405 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 9536 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 18069 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24317 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30214 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2015 | 81748 | 0.000 |
Why?
|